EUVIMEDEUVIMED entdecken
Crossref

Comparison of a Novel Blood-Based Hemato-Immune Response Score (HIRS) with IMDC and MSKCC Models in Metastatic Renal Cell Carcinoma

Mustafa Ersoy

Eurasian Journal of Medical Investigation · 2026 · 18-24

DOI: 10.14744/ejmi.263018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eurasian Journal of Medical Investigation, 2026. Verfasst von Mustafa Ersoy.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ersoy, M. (2026). Comparison of a Novel Blood-Based Hemato-Immune Response Score (HIRS) with IMDC and MSKCC Models in Metastatic Renal Cell Carcinoma. Eurasian Journal of Medical Investigation, 18-24. https://doi.org/10.14744/ejmi.263018

Vancouver

Ersoy M. Comparison of a Novel Blood-Based Hemato-Immune Response Score (HIRS) with IMDC and MSKCC Models in Metastatic Renal Cell Carcinoma. Eurasian Journal of Medical Investigation. 2026:18-24. doi:10.14744/ejmi.263018

BibTeX
@article{Ersoy2026,
  author = {Ersoy, Mustafa},
  title = {Comparison of a Novel Blood-Based Hemato-Immune Response Score (HIRS) with IMDC and MSKCC Models in Metastatic Renal Cell Carcinoma},
  journal = {Eurasian Journal of Medical Investigation},
  year = {2026},
  pages = {18--24},
  doi = {10.14744/ejmi.263018}
}
Kostenlos starten →